probucol has been researched along with DDD MPGNII in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, S | 1 |
| Shimizu, M | 1 |
| Urushihara, M | 1 |
| Tsuchiya, K | 1 |
| Yoshizumi, M | 1 |
| Tamaki, T | 1 |
| Nishiyama, A | 1 |
| Kawachi, H | 1 |
| Shimizu, F | 1 |
| Quinn, MT | 1 |
| Lambeth, DJ | 1 |
| Kagami, S | 1 |
1 other study available for probucol and DDD MPGNII
| Article | Year |
|---|---|
Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Biopsy, Needle; Blotting, Western; D | 2006 |